QuickVue® SARS Antigen Test
- UID
- IMP/IVD/2021/000444_1331098f5074b793a0544cb4aeff6f58_04c0f338cd638fb2030afb297b8a81a5
- Device class
- Class C
- Brand name
- QuickVue® SARS Antigen Test
- License holder
- M/s Parekh Integrated Services Pvt. Ltd.
- Approving authority
- CDSCO
- Product information
- The QuickVue SARS Antigen Test is a lateral flow immunoassay that allows for the rapid, qualitative detection of the nucleocapsid protein antigen from SARS-CoV-2 in anterior nares (QuickVue® SARS Antigen Test) swab specimens directly from individuals who are suspected of COVID-19 by their healthcare provider within the first five days of the onset of symptoms. The QuickVue SARS Antigen test does not differentiate between SARS-CoV and SARS-CoV-2.
QuickVue® SARS Antigen Test is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/IVD/2021/000444_1331098f5074b793a0544cb4aeff6f58_04c0f338cd638fb2030afb297b8a81a5. This device is marketed under the brand name QuickVue® SARS Antigen Test. The license holder is M/s Parekh Integrated Services Pvt. Ltd., and it is classified as Device Class Class C. The approving authority is CDSCO.
This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.